Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of the Fixed-dose Combination of Valsartan Plus Chlorthalidone Vs Valsartan or Chlorthalidone Alone in the Treatment of Arterial Hypertension, Open-label, Controlled, Randomized and Multicenter Trial

NCT01850160 is registered in ClinicalTrials.gov with Farma de Colombia SA as lead sponsor.

NCT NCT01850160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01850160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of the Fixed-dose Combination of Valsartan Plus Chlorthalidone Vs Valsartan or Chlorthalidone Alone in the Treatment of Arterial Hypertension, Open-label, Controlled, Randomized and Multicenter Trial
Lead sponsor
Farma de Colombia SA
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2013
Completion date
May 31, 2015
Enrollment
124 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension